1. Bristol-Myers gets breakthrough status for Opdivo-Yervoy combo in liver cancer — Roche SMA trial of risdiplam hits target— AbbVie submits sNDA for Imbruvica/Rituximab combo for CLL — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Organogenesis

Anonymous board for Organogenesis


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    6
    Views:
    678
  2. anonymous
    Replies:
    54
    Views:
    18,476
  3. anonymous
    Replies:
    51
    Views:
    7,955
  4. anonymous
    Replies:
    1
    Views:
    628
  5. anonymous
    Replies:
    12
    Views:
    2,190
  6. anonymous
    Replies:
    19
    Views:
    7,816
  7. anonymous
    Replies:
    9
    Views:
    4,336
  8. Anonymous
    Replies:
    2
    Views:
    1,303
  9. anonymous
    Replies:
    2
    Views:
    1,307
  10. anonymous
    Replies:
    3
    Views:
    1,769
  11. anonymous
    Replies:
    22
    Views:
    8,367
  12. anonymous
    Replies:
    10
    Views:
    3,296
  13. anonymous
    Replies:
    0
    Views:
    1,223
  14. anonymous
    Replies:
    3
    Views:
    2,272
  15. anonymous
    Replies:
    17
    Views:
    4,904
  16. anonymous
    Replies:
    12
    Views:
    2,184
  17. anonymous
    Replies:
    28
    Views:
    12,423
  18. anonymous
    Replies:
    5
    Views:
    5,875
  19. anonymous
    Replies:
    5
    Views:
    2,091
  20. anonymous
    Replies:
    2
    Views:
    2,362

Thread Display Options

Loading...